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Background: There are many reports regarding various medical institutions’ attempts at incident prevention, but the
relationship between incident types and impact on patients in drug name errors has not been studied. Therefore, we
analyzed the relationship between them, while also assessing the relationship between preparation and inspection
errors. Furthermore, the present study aimed to clarify the incident types that lead to severe patient damage.
Methods: The investigation object in this study was restricted to “drug name errors”, preparation and inspection errors
in them were classified into three categories (similarity of drug efficacy, similarity of drug name, similarity of drug
appearance) or two groups (drug efficacy similarity (+) group, drug efficacy similarity (−) group). Then, the relationship
between preparation and inspection errors was investigated in three categories, the relationship between incident
types and impact on patients was examined in two groups.
Results: The frequency of preparation errors was liable to be caused by the following order: similarity of drug efficacy
> similarity of drug name > similarity of drug appearance. In contrast, the rate of inspection errors was liable to be
caused by the following order: similarity of drug efficacy < similarity of drug name < similarity of drug appearance. In
addition, the number of preparation errors in the drug efficacy similarity (−) group was fewer than that in the drug
efficacy similarity (+) group. However, the rate of inspection errors in the drug efficacy similarity (−) group was
significantly higher than that in the drug efficacy similarity (+) group. Furthermore, the occupancy rate of preparation
errors, incidents more than Level 0, 1, and 2 in the drug efficacy similarity (−) group increased gradually according to
the rise of patient damage.
Conclusions: Our results suggest that preparation errors caused by the similarity of drug appearance and/or drug
name are likely to lead to the incidents (inspection errors), and these incidents are likely to cause severe damage to
patients subsequently.
Keywords: Drug name errors, Preparation errors, Inspection errors, Incidents, Impact on patientsBackground
Medical care security measures have advanced, but med-
ical accidents and incidents continue to occur. Needless
to say, pharmacists should make every effort to prevent
incidents caused by their own errors. We have been
working on countermeasures for preventing incidents
regarding oral and external drugs in the pharmaceutical
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unless otherwise stated.been able to maintain the occurrence rate of incidents of
these drugs in the range from 0.027 to 0.036% for seven
years, ever since April 2007 [1-3]. However, it is very
difficult for pharmacists to prevent all incidents in
actuality.
In general, it is recognized that incidents involved in
drug name errors can easily cause profound damage to
patients in terms of problem severity, but it is not clear
what impact the occurrence of these incidents might
have on patients subsequently. There are many reportsis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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drugs in various medical institutions [1-5], and many ana-
lytical studies have been conducted regarding the prob-
ability of drug name confusion [6-11], but the relationship
between incident types and impact on patients in drug
name errors has not been studied. In this study, prepar-
ation and inspection errors involved in drug name errors
were classified into three categories (similarity of drug
efficacy, similarity of drug name, similarity of drug
appearance) or two groups (drug efficacy similarity (+)
group, drug efficacy similarity (−) group). Then, the
relationship between preparation and inspection errors
was analyzed in three categories, the relationship be-
tween incident types and impact on patient was exam-
ined in two groups.
Methods
The investigation period and object
The investigation period lasted seven years, from April
2007 to March 2014. The investigation object was prep-
aration and inspection errors amidst inpatient punctual
prescriptions. Among them, the errors of narcotics,
powders, injections, and tablets divided by an automatic
packaging machine were excluded from this study
because of the difference in dispensing procedures.
Furthermore, the definitive investigation object in this
study was restricted to “drug name errors”, not in-
cluding “drug count errors”, “drug content errors”
and so on.
Preparation errors were equivalent to dispensing the
drugs incorrectly, and these data was self-reported by
pharmacy inspectors. Also, inspection errors were equi-
valent to overlooking the preparation errors caused by
dispensers, and these data was reported by other med-
ical staff. In Kyushu University Hospital, prescriptions
for dispensing are printed in the pharmaceutical de-
partment using the prescription operating system, and
medicines in the pharmaceutical department are ar-
ranged in accordance with the classification of drug
efficacy. In addition, the contents of prescriptions and
the years of pharmacist’s experience were not analyzed
in this study.
Definition of incidents and classification of incident
impact on patients
We defined the errors detected by other medical staff
or inpatients after being overlooked by pharmacists or
inspectors as “incidents.” According to the provisions
of the National University Hospital in Japan, impact on
patients of the incidents was classified into 6 stages
(Levels 0–5) as described below.
Level 0: Incorrect drug was delivered to other medical
staff or patient, but it was not used.Level 1: Incorrect drug was used by a patient, but
actual patient damage was not caused.
Level 2: Moderate damage was caused to patient, but
treatment was not needed.
Level 3: Provisional or continual treatment was needed.
Level 4: Severe damage to patient remained.
Level 5: Patient died.
Definition of preparation and inspection errors
We defined the errors detected by the pharmacy in-
spector as “preparation errors,” the errors not detected
by pharmacy inspectors as “inspection errors.” In this
study, it was considered the practical preparation errors
to be equivalent to all errors, including incidents more
than Level 0, because incidents more than Level 0 were
simply not detected by the pharmacists at the point of
inspection.
In short, the number of preparation errors con-
tained all inspection errors, the number of inspection
errors contained the incidents of Levels 0–5, and
inspection errors had an equivalent meaning to “inci-
dents more than Level 0.” The definition of preparation
and inspection errors was summarized as described
below.
Preparation errors: The errors that were revealed
to be incorrect afterward. They were equivalent to the
“all errors” category, and these included errors detected
by pharmacy inspector.
Inspection errors: The errors that were not detected
by pharmacy inspectors, and they are equivalent in
meaning to “incidents more than Level 0”.
Classification of preparation and inspection errors into
three categories
Preparation and inspection errors involved in drug name
errors were classified into four categories: (1) similarity
of drug efficacy, (2) similarity of drug name, (3) similarity
of appearance, and (4) no similarities. Also, the category
of no similarities (4) was used as a comparison (control)
group.
We defined the drugs having common efficacy in
insurance adaptation as “similarity of drug efficacy”.
Also, the trade names of Japanese drugs are expressed
by katakana in most cases, and katakana expression in
Japanese consists of both orthographic (i.e., spelling) and
phonological (i.e., pronunciation) factors. Therefore,
the trade name of the katakana was converted into a
Romanized version of Japanese (non-English words
Romanized using Hepburn’s method), because it repre-
sents the exact features of the katakana. Then, we defined
the drugs having commonality of continuous letters in
Romanized Japanese as “similarity of drug name”. Fur-
thermore, we defined the drugs having similar colors,
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they were evaluated by the both tablets/capsules and
blister-packages.
In the process of the classification of these errors
into three categories (1) - (3), the errors were able
to be divided into seven detailed error types (a) - (g)
as follows: (a) similarity of drug efficacy alone, (b)
similarity of drug name alone, (c) similarity of drug
appearance alone; three more, (d) similarity of drug
efficacy and name, (e) similarity of drug efficacy and
appearance, (f ) similarity of drug name and appearance;
and one, (g) similarity of drug efficacy, name, and
appearance.
Also, we defined the errors that did not overlap
with other similarities as “single similarity class: (a) + (b) +
(c),” errors overlapped with two similarities as “double
similarity class: (d) + (e) + (f)”, and errors overlapped with
three similarities as “triple similarity class: (g).” Further-
more, the control group was regarded as “no similarity
class”. Then, the differences in the rates of inspection er-
rors were analyzed among four error classes (single,
double, triple and no similarity class) and among three
error types (a) - (c) in the single similarity class and an-
other three error types (d) - (f ) in the double similarity
class. Additional file 1: Table S1 shows the classification
method of categories (1) - (3) and the actual cases of
preparation errors.Figure 1 Number of preparation and inspection errors in three categ
inspection errors involved in drug name errors were 704 and 73, respective
categories (similarity of drug efficacy, similarity of drug name, similarity of d
drug efficacy similarity (−) group) were 600 and 66, respectively. The prepa
(A) and two error groups (B). Numerical values in the circle represent the nReclassification of preparation and inspection errors, and
incident impact on patients in two groups
It was considered that impact on patients of the incidents
involved in drug name errors would be affected by either
the presence or absence of drug efficacy similarity. There-
fore, we reclassified preparation errors, inspection er-
rors, and the subsequent incident impact on patients
into two groups: “drug efficacy similarity (+) group”
and “drug efficacy similarity (−) group.” Then, the re-
lationship between preparation and inspection errors
was analyzed, and the relationship between incident types
and their impact on patients was examined in two groups.
Analysis of preparation and inspection errors
The differences in preparation errors among the error
classes, types and groups were analyzed by the number of
errors based on the number of total prescriptions over
seven years, because each number indicates the frequency
of occurrence on condition that total prescription number
is invariable. On the other hand, the differences in inspec-
tion errors among them were analyzed by the rate of er-
rors that calculated by dividing the number of inspection
errors by that of preparation errors.
Statistical analysis
The data were analyzed with a Chi-squared test and a
Ryan test. P values of <0.05 were considered to beories (A) and two groups (B). The total numbers of preparation and
ly. Also, the numbers of preparation and inspection errors in three
rug appearance) or two groups (drug efficacy similarity (+) group,
ration and inspection errors were classified into seven error types
umber of preparation errors (inspection errors).
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analyze differences in the rates of inspection errors among
four error classes (single, double, triple and no similarity
class) and between two groups (drug efficacy similarity (+)
group, drug efficacy similarity (−) group). Also, a Ryan test
as multiple comparison was used to analyze differences in
the rates of inspection errors among three error types (a) -
(c) in the single similarity class and another three error
types (d) - (f) in the double similarity class.
Results
Numbers of preparation and inspection errors
Over the seven years, 664,887 inpatient punctual pre-
scriptions were given. The total numbers of preparation
and inspection errors involved in drug name errors were
704 and 73, respectively. Also, the numbers of prepar-
ation and inspection errors in three categories (similarity
of drug efficacy, similarity of drug name, similarity of
drug appearance) or two groups (drug efficacy similarity
(+) group, drug efficacy similarity (−) group) were 600Figure 2 Relationship between number of preparation errors and rate
errors in three classes (single similarity class, double similarity class, triple si
the same classes were 12.7% (43/338), 9.6% (22/228), and 2.9% (1/34), respe
errors and the rate of inspection errors, respectively. The differences in the
(single, double, triple and no similarity class). There were no significant differe
data were analyzed with a Chi-squared test. P values of <0.05 were considereand 66, respectively. Figure 1 shows the number of prep-
aration and inspection errors in three categories (A) and
two groups (B).
Relationship between number of preparation errors and
rate of inspection errors in four classes
Figure 2 shows the relationship between the number of
preparation errors and the rate of inspection errors in four
classes. The number of preparation errors and the rate of
inspection errors in the control group (no similarity class)
were 104 and 6.7% (7/104). Also, the numbers of prepar-
ation errors in three classes (single, double, and triple
similarity class) were 338, 228, and 34, the rates of inspec-
tion errors in the same classes were 12.7% (43/338), 9.6%
(22/228), and 2.9% (1/34), respectively.
There were no significant differences in the rates of
inspection errors among four classes (P = 0.1305). Also, a
positive correlation was observed between the numbers of
preparation errors and the rates of inspection errors in
three classes (single, double, and triple similarity class).of inspection errors in four classes. The numbers of preparation
milarity class) were 338, 228, and 34, the rates of inspection errors in
ctively. The bar and symbol represent the number of preparation
rates of inspection errors were analyzed among four error classes
nces in the rates of inspection errors among four classes (P = 0.1305). The
d to be statistically significant.
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rate of inspection errors in the single and double
similarity class
Figure 3 shows the relationship between the number
of preparation errors and the rate of inspection errors
among three error types (a) - (c) in the single similar-
ity class and another three error types (d) - (f ) in the
double similarity class. In the single similarity class,
the numbers of preparation errors in the error type
(a), (b), (c) were 242, 74, 22, and the rates of inspec-
tion errors in the same error type were 10.7% (26/
242), 14.9% (11/74), 27.3% (6/22), respectively. In the
double similarity class, the numbers of preparation errors
in error types (d), (e), (f) were 163, 49, 16, and the rates of
inspection errors were 6.7% (11/163), 14.3% (7/49), 25.0%
(4/16), respectively.Figure 3 Relationship between number of preparation errors and rate
In the single similarity class, the numbers of preparation errors in the error typ
same error type were 10.7% (26/242), 14.9% (11/74), 27.3% (6/22), respectively
types (d), (e), (f) were 163, 49, 16, and the rates of inspection errors were 6.7%
represent the number of preparation errors and the rate of inspection errors,
analyzed among three error types (a) - (c) in the single similarity class and an
significant differences in the rates of inspection errors between error type (a)
double similarity class (P < 0.05). The data were analyzed with a Ryan test. P vThere were significant differences in the rates of in-
spection errors between error type (a) and (c) in the sin-
gle similarity class, between error type (d) and (f ) in the
double similarity class (P < 0.05). Also, an inverse correl-
ation was observed between the numbers of preparation
errors and the rates of inspection errors in both the sin-
gle and double similarity classes.
Furthermore, when we compared the rates of inspec-
tion errors between error types (d) and (e) based on the
common similarity (similarity of drug efficacy) for both,
it was revealed that the rate of inspection errors having
“similarity of drug appearance” was higher than that hav-
ing “similarity of drug name”. By comparing the rates of
inspection errors between error type (d) and (f ), between
error type (e) and (f ) in the double similarity class, it
was revealed comprehensively that the rate of inspectionof inspection errors in the single and double similarity class.
e (a), (b), (c) were 242, 74, 22, and the rates of inspection errors in the
. In the double similarity class, the numbers of preparation errors in error
(11/163), 14.3% (7/49), 25.0% (4/16), respectively. The bar and symbol
respectively. The differences in the rates of inspection errors were
other three error types (d) - (f) in the double similarity class. There were
and (c) in the single similarity class, between error type (d) and (f) in the
alues of <0.05 were considered to be statistically significant.
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similarity of drug efficacy < similarity of drug name <
similarity of drug appearance, while the frequency of
preparation errors was liable to be a result of the reverse
order.
Relationship between number of preparation errors and
rate of inspection errors in two groups
Figure 4 shows the relationship between the number of
preparation errors and the rate of inspection errors in
two groups (drug efficacy similarity (+) group, drug effi-
cacy similarity (−) group). In the drug efficacy similarity
(+) group, the number of preparation errors was 488,
and the rate of inspection errors was 9.2% (45/488).
In the drug efficacy similarity (−) group, the numberFigure 4 Relationship between number of preparation errors and rate
errors was 488, and the rate of inspection errors was 9.2% (45/488) in the d
112, and the rate of inspection errors was 18.8% (21/112) in the drug effica
preparation errors and the rate of inspection errors, respectively. The differe
groups (drug efficacy similarity (+) group, drug efficacy similarity (−) group
between two groups (P < 0.05). The data were analyzed with a Chi-squaredof preparation errors was 112, and the rate of inspec-
tion errors was 18.8% (21/112).
There was a significant difference in the rates of
inspection errors between two groups (P < 0.05). Also,
an inverse correlation was observed between the numbers
of preparation errors and the rates of inspection errors in
two groups.
Relationship between incident types and impact on
patients
Figure 5 shows the relationship between incident types
and their impacts on patients. There were no incidents
more than Level 3. The occupancy rates of preparation
errors, incidents more than Level 0, 1, and 2 in the drug
efficacy similarity (+) group were 81.3% (488/600), 68.2%of inspection errors in two groups. The number of preparation
rug efficacy similarity (+) group. The number of preparation errors was
cy similarity (−) group. The bar and symbol represent the number of
nces in the rates of inspection errors were analyzed between two
). There was a significant difference in the rates of inspection errors
test. P values of <0.05 were considered to be statistically significant.
Figure 5 Relationship between incident types and impact on patients. The occupancy rates of preparation errors, incidents more than Level
0, 1, and 2 in the drug efficacy similarity (+) group were 81.3% (488/600), 68.2% (45/66), 57.1% (4/7), and 25.0% (1/4), respectively. On the other
hand, the same rates in the drug efficacy similarity (−) group were 18.7% (112/600), 31.8% (21/66), 42.9% (3/7), and 75.0% (3/4), respectively.
Consequently, the occupancy rate of preparation errors, incidents more than Level 0, 1, and 2 in the drug efficacy similarity (−) group increased
gradually according to the rise of patient damage.
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the other hand, the same rates in the drug efficacy simi-
larity (−) group were 18.7% (112/600), 31.8% (21/66),
42.9% (3/7), and 75.0% (3/4), respectively.
The usage rate of patients after delivering the incorrect
medicines (more than Level 1/ more than Level 0) was
8.9% (4/45) in the drug efficacy similarity (+) group,
while the same rate was 14.3% (3/21) in the drug efficacy
similarity (−) group. Furthermore, the occurrence rate of
moderate damage to patients after taking the incorrect
medicines (more than Level 2/ more than Level 1) was
25.0% (1/4) in the drug efficacy similarity (+) group,
while the same rate was 100% (3/3) in the drug efficacy
similarity (−) group.Discussion
A positive correlation was observed between the num-
bers of preparation errors and the rates of inspection er-
rors in three classes (single, double, and triple similarity
class). On the other hand, an inverse correlation was ob-
served between them in the single and double similarity
class. In short, the frequency of preparation errors is
liable to be caused by the following order: similarity of
drug efficacy > similarity of drug name > similarity of
drug appearance, while the rate of inspection errors is
liable to be caused by the following order: similarity of
drug efficacy < similarity of drug name < similarity of
drug appearance. These results suggest that preparation
and inspection errors differ entirely in terms of their
Tsuji et al. Journal of Pharmaceutical Health Care and Sciences  (2015) 1:11 Page 8 of 8occurrence factors. Pharmacists are likely to dispense in-
appropriate drugs resembling the correct drug in their
efficacy, because pharmaceutical department medicines
are arranged in accordance with the classification of drug
efficacy. On the other hand, pharmacy inspectors are likely
to overlook the preparation errors caused by the similarity
of drug appearance and/or name, because they tend to
make judgments based on the color, shape, and size of a
drug, or based on parts of letters in a drug’s name.
Interestingly, the number of preparation errors in the
drug efficacy similarity (−) group was fewer than that in
the drug efficacy similarity (+) group, while the rate of
inspection errors in the drug efficacy similarity (−) group
was significantly higher than that in the drug efficacy
similarity (+) group. Furthermore, the occupancy rate of
preparation errors, incidents more than Level 0, 1, and 2
in the drug efficacy similarity (−) group increased grad-
ually according to the rise of patient damage. These re-
sults suggest that preparation errors caused by the
similarity of drug appearance and/or name (preparation
errors not caused by the similarity of drug efficacy) are
liable to lead to the incidents (inspection errors), fur-
thermore, these incidents are liable to cause the severe
patient damage subsequently.
For these reasons, pharmacy inspectors need to take
steps to prevent such inspection errors. As a counter-
measure for them, it would be useful for pharmacy in-
spectors to confirm additionally the “identification code”
indicated on the exterior of each medicine. For example,
the identification codes corresponding to medicines are
supposed to be indicated on the prescription for dis-
pensing by enrolling them at our hospital pharmacy.
Therefore, it is possible for us to compare a pair of the
same codes on both exterior of medicine and prescrip-
tion for dispensing. Because the identification code is
typically a simple and unique mark with the combin-
ation of number, symbol, and so on, it is unlikely for
pharmacy inspectors to be influenced by preconceptions
in terms of comparing the two codes.
Conclusions
In conclusion, the preparation errors caused by the simi-
larity of drug appearance and/or drug name are likely to
lead to the incidents (inspection errors). Furthermore,
these incidents are likely to cause severe damage to pa-
tients subsequently. It is important for pharmacists to
utilize these results for preventive measure of errors and
for pharmaceutical education.Additional file
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